Clinical trial reportClinical pharmacology in drug developmentPublished
Exposure-Response Relationship of Dostarlimab in Primary Advanced/Recurrent Endometrial Cancer: Results From Interim Analysis 2 of Part 1 of the RUBY Trial
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, GSK, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, GSK, Temple Health
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Clinical pharmacology in drug development
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Endometrial Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Models, Biological; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized
- PubMed ID
- 42555284
- PubMed Central ID
- PMC13440458
- Open access
- Yes, open
- Added to directory
- Source checked